Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 2,336,489	$ 1,008,145
Cost of revenue	623,152	318,651
Gross margin	1,713,337	689,494
Operating expenses:
Research and development	525,967	506,953
Selling, general and administrative	4,119,802	3,604,968
Total operating expenses	4,645,769	4,111,921
Loss from operations	(2,932,432)	(3,422,427)
Other expense (income)
Change in fair value of derivative liabilities		(82,101)
Interest income and other expense, net	119	135,209
Non-cash interest expense, debt discount		166,643
Loss on extinguishment of debt		159,202
Total other expense (income)	119	378,953
Loss before income taxes	(2,932,551)	(3,801,380)
Income tax expense	28,243	613
Net loss	(2,960,794)	(3,801,993)
Deemed dividend on repricing of warrants		670,632
Net loss attributable to common stockholders	$ (2,960,794)	$ (4,472,625)
Weighted average number of common shares outstanding:
Basic and diluted	5,191,417	1,778,708
Net loss per share attributable to common stockholders
Basic and diluted	$ (0.57)	$ (2.51)